BLFS - Biolife Solutions Inc
IEX Last Trade
25.87
-0.050 -0.193%
Share volume: 394,425
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$25.92
-0.05
-0.19%
Fundamental analysis
17%
Profitability
0%
Dept financing
13%
Liquidity
75%
Performance
20%
Performance
5 Days
2.29%
1 Month
7.65%
3 Months
18.99%
6 Months
51.35%
1 Year
98.77%
2 Year
10.17%
Key data
Stock price
$25.87
DAY RANGE
N/A - N/A
52 WEEK RANGE
$8.92 - $26.73
52 WEEK CHANGE
$0.93
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Michael Rice
Region: US
Website: https://biolifesolutions.com/
Employees: 168
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://biolifesolutions.com/
Employees: 168
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
Recent news